Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney disease
Pharma
Novartis, Apellis roll out rival datasets in rare kidney disease
Novartis and Apellis revealed detailed data on iptacopan and pegcetacoplan this weekend as they race for the prize in a type of rare kidney disease.
Fraiser Kansteiner
Oct 28, 2024 10:03am
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Oct 25, 2024 8:43am
Roche's Gazyva chases new kidney disease use with phase 3 win
Sep 26, 2024 11:30am
Despite trial scare, Travere's IgAN drug wins full FDA approval
Sep 5, 2024 5:40pm
Watch out, Novartis. Apellis scores major win in kidney diseases
Aug 8, 2024 2:28pm
Novartis’ Fabhalta wins expanded FDA nod in IgAN
Aug 8, 2024 3:18am
